FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and chronic kidney disease.
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.
Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...
A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Protein takes longer to digest than simple carbohydrates and helps stabilize blood sugar levels. High-protein foods include ...
Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...
A healthy diet with regular exercise can help with sustainable weight loss. However, the use of Ozempic may contribute to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback